Dec. 26, 2012
-- American Conference Institute
is very excited to announce its highly-anticipated Latin America Summit on Pharmaceutical & Medical Device Regulatory Compliance
, scheduled for March 11-13, 2013 in Panama City, Panama. As recent high-profile settlements by some of the industry’s major stakeholders have highlighted, the government has made continued enforcement initiatives a top priority, especially within the pharmaceutical, biotechnology and medical device sectors. With increased agency scrutiny expected over the next 12 months, take this opportunity to benchmark your internal protocols against those of you peers at Allergan, Inc., AstraZeneca, Bayer Pharmaceuticals, BioMarin Pharmaceuticals Inc., Bristol Myers Squibb Co., Edwards Lifesciences, GlaxoSmithKline Vaccines, Grünenthal, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Roche, Teva Pharmaceuticals Americas and many more.
Learn the nuances and intricacies of conducting clinical trials in Latin America, and hear from senior in-house counsel, compliance officers
and business executives
from within the life sciences industry as they share their expertise regarding local legislation and enforcement initiatives.
In addition to the vast learning opportunities, the Latin America Summit will provide numerous networking opportunities during breaks and lunch. Gain valuable face-to-face time with your industry peers and benchmark your regulatory compliance practices.
For more information, pleae visit us http://www.americanconference.com/PharmaLatAm
. The agenda is also available in Spanish.